SCHEDULE 13G/AAccepted May 12, 9:48 PM ET
Aclaris Therapeutics, Inc. SCHEDULE 13G/A
Accepted (ET)
9:48 PM
May 12, 2026
Filed
May 12, 2026
Documents
1
Size
13.7 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.